Benzo Withdrawal Fatigue and How a Slow Taper Helps

Is fatigue a real benzodiazepine withdrawal symptom, or is something else going on?

Fatigue is a listed benzodiazepine withdrawal symptom. Chapter III of the Ashton Manual, at benzo.org.uk, prints “fatigue, influenza-like symptoms” in the physical column of its Table 1, next to weakness, which Professor C. Heather Ashton called “jelly legs.” Patients tapering off of a benzodiazepine do not imagine their exhaustion, and they did not cause it.

Patients often describe sleep that repairs nothing, a walk to the mailbox that feels like a hike, and a heaviness in the limbs that a day on the couch does not lift. Family members sometimes read this as depression, laziness, or proof that the person needs the drug back. It is none of those.

Fatigue is the nervous system doing hard work, and it is expected during a taper. So, why would taking less of a sedative leave a person more tired?

Taking less of a sedative should make a person more alert. The opposite happens, and there is a reason.

Benzodiazepines amplify gamma-aminobutyric acid (GABA), the brain’s main calming signal. Chapter I of the Manual explains that with continued use the GABA and benzodiazepine receptors become less responsive, so the brain’s own calming action is turned down to make room for the drug’s. When the dose comes down, less braking is left than there was before the drug was started.

A nervous system with too little braking does not rest. Tension, tremor, a fast pulse, and a mind that will not idle burn fuel around the clock, and Professor Ashton wrote that all this constant activity contributes to a feeling of fatigue and weakness. Insomnia is on the same symptom table, so most days begin in deficit.

Imagine holding a door shut against a strong wind for a whole afternoon. By evening you have not walked a step, and yet you are worn out. While the analogy is not perfect, it explains why rest alone does not fix withdrawal fatigue: the wind has to die down, and a slow taper is what lets it die down.

The Manual also notes that some people who have taken a benzodiazepine for years feel withdrawal symptoms while still taking it, because tolerance has developed. In fact, a patient may arrive at a first consultation already exhausted, before a single reduction. That person is physically dependent, and dependence is not addiction: the drug was taken as prescribed, the brain adapted as any brain would, and the treatment is a gradual medical taper, not an addiction program.

Fatigue is not a reason to speed up, and it is not a reason to stop.

Exhausted patients reason in two dangerous directions, and the first is to get it over with by cutting faster or skipping the last step. The 2020 boxed-warning update from the United States Food and Drug Administration (FDA) warns that abrupt discontinuation or rapid dosage reduction may precipitate acute withdrawal reactions, including seizures, which can be life-threatening. Call emergency services for a seizure or any other medical emergency.

The second direction is to go back up to the old dose. Chapter II of the Manual advises, as far as possible, never to go backwards, and adds that a patient can stand still at any stage and take a vacation from further reductions for a few weeks. That pause is called a hold, and it is the main tool for managing fatigue.

Fortunately, a hold costs nothing but time. If fatigue is disabling, the doctor must slow the taper or hold it, and if the patient feels steady, patient and doctor may agree to take the next step. The Manual is plain about who decides: the patient must be in control and go at the pace that is comfortable for them.

The shape of the taper matters more than any number in it.

Chapter III of the Manual states that withdrawal symptoms can be minimized and largely avoided by slow tapering tailored to the person, and Chapter II suggests reductions of up to one tenth of the dose at each step, with the steps shrinking as the dose gets lower. The Maudsley Deprescribing Guidelines describe the same idea as hyperbolic tapering: each reduction is a fraction of the current dose, not the starting dose, so the final steps are the smallest of all.

The numbers belong to the patient and the prescriber. Dr. Mark Leeds does not publish schedules, because a schedule that fits one nervous system can harm another.

Fatigue also tells the prescriber how the taper is going: a wave of tiredness after a reduction that fades before the next one is the expected shape. Tiredness that deepens week over week, or no longer lifts between reductions, means the taper is running ahead of the nervous system, and that is the moment to tell the doctor. Nobody has ever been given a prize for finishing a taper on schedule.

Klonopin fatigue lags behind the dose change, because the drug leaves slowly.

Klonopin (clonazepam) deserves its own paragraph. Table 1 in Chapter I of the Manual gives clonazepam a half-life of 18 to 50 hours, so after a reduction the blood level drifts down over days rather than hours. The fatigue from a cut made on Monday may not arrive until Thursday, and patients often blame a poor night or a skipped meal instead.

So, with clonazepam a step cannot be judged on the first morning. The full effect of a cut often takes a week or more to show, and the next cut should wait until the last one has landed. Relief from a hold takes days to show for the same reason.

A short-acting drug such as Xanax (alprazolam), listed in the same table with a half-life of six to twelve hours, lets blood levels rise and fall several times a day, and every trough is a small withdrawal. Clonazepam spares patients that clock, and instead hides the effect of each reduction for days.

Clonazepam is long-acting only next to alprazolam. Next to Valium (diazepam) it is not: Chapter II of the Manual says Klonopin is eliminated much faster than diazepam and that a smooth, slow fall in blood level is hard to achieve with it, while the same Chapter I table gives diazepam a half-life of up to 200 hours. That is why the Manual’s crossover taper to diazepam applies to clonazepam as much as to the short-acting drugs.

The Manual’s Chapter II schedules substitute diazepam for clonazepam, and the Manual adds that some people find that particular switch difficult. So, whether to cross over, and how quickly, is a decision for patient and prescriber together, and Dr. Leeds follows the crossover where it helps.

What helps in the meantime, and what quietly makes things worse.

Comfort measures are supportive, and only supportive. Rest without guilt, a short walk rather than a workout, regular meals, and steady hydration make a tired day more bearable, while overexertion tends to bring on a wave and caffeine borrows energy from the night. Digestive symptoms are common in withdrawal and sap energy on their own, and there is a separate article on benzo belly and what to eat during a taper.

Unfortunately, the internet sells a remedy for every symptom on the Manual’s table. Valerian and the other herbs promoted for calm and sleep act on the same GABA system the taper is trying to settle, so adding a second sedative while removing the first muddies the picture and can add to the sedation. The evidence for supplements in benzodiazepine withdrawal is limited, and anything taken for energy or sleep belongs in the conversation with the prescriber before it is started.

Time is the treatment, and the taper sets how fast it works.

The Manual says withdrawal symptoms wax and wane from day to day and week to week, and that windows of normality, a few hours or days of feeling well, appear after some weeks and then grow more frequent and longer. Fatigue usually lifts in windows before it leaves for good. Nobody can honestly put a date on it, and a doctor who promises one is guessing.

Many patients were told, years ago, that the drug was safe to take for as long as they liked, and now they are told that their exhaustion is a new illness needing a new prescription. Fatigue during a supervised taper is a withdrawal symptom, and the honest response is pace, patience, and a prescriber who listens.

Dr. Leeds’ practice in Fort Lauderdale, Florida, offers one service: medically supervised benzodiazepine and z-drug tapering for patients in Florida, as a concierge practice rather than through insurance. The taper is gradual and patient-directed over months or longer, following the Ashton Manual crossover to diazepam where it helps and hyperbolic reductions per the Maudsley Deprescribing Guidelines, with a hold whenever fatigue says the nervous system needs one. Contact Dr. Leeds to ask about a supervised taper.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.